Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Cannabinoids in Obesity
Francesca Rossi, Francesca Punzo, Giuseppina Rosaria Umano, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2690-2690
Open Access | Times Cited: 85

Showing 51-75 of 85 citing articles:

Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay
Han Zhou, Xing‐Rong Peng, Tao Hou, et al.
Journal of Ethnopharmacology (2019) Vol. 246, pp. 112218-112218
Closed Access | Times Cited: 14
Vitamin D deficiency promotes accumulation of bioactive lipids and increased endocannabinoid tone in zebrafish
Megan M. Knuth, Whitney L. Stutts, Morgan M. Ritter, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100142-100142
Open Access | Times Cited: 12
Association Between Triglyceride-Glucose Index and Waist-To-Hip Ratio with Type 2 Diabetic Retinopathy in the Chinese Population: A Cross-Sectional Study
Yu Wang, Ying Miao, Qin Wan
Endocrine Research (2024), pp. 1-10
Closed Access | Times Cited: 1
Succinic Acid Improves the Metabolism of High-Fat Diet-Induced Mice and Promotes White Adipose Browning
Yuxuan Yang, Liang Luo, Yiqi Li, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3828-3828
Open Access | Times Cited: 1
In-silico investigations of selective miRNA-gene targets and their validation studies in obstructive sleep apnea (OSA) patient cohorts
Sartaj Khurana, Kamran Waidha, Randeep Guleria, et al.
Computational Biology and Chemistry (2020) Vol. 87, pp. 107264-107264
Closed Access | Times Cited: 12
Large library docking for cannabinoid-1 receptor agonists with reduced side effects
Tia A. Tummino, Christos Iliopoulos‐Tsoutsouvas, João M. Bráz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
The Use of Cannabidiol in Metabolic Syndrome—An Opportunity to Improve the Patient’s Health or Much Ado about Nothing?
Michał Wiciński, Anna Fajkiel-Madajczyk, Zuzanna Kurant, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4620-4620
Open Access | Times Cited: 4
The impact of cannabinoid receptor 1 absence on mouse liver mitochondria homeostasis: insight into mitochondrial unfolded protein response
Rosalba Senese, Giuseppe Petito, Elena Silvestri, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models
Paula Morales, Patricia H. Reggio
Advances in experimental medicine and biology (2020), pp. 47-65
Closed Access | Times Cited: 10
Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases
Leila Hosseinzadeh Anvar, Ali Ahmadalipour
BioFactors (2022) Vol. 49, Iss. 1, pp. 62-78
Closed Access | Times Cited: 7
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Monika Vidlarova, Emil Berta, Petr Prášil, et al.
Translational Lung Cancer Research (2022) Vol. 11, Iss. 10, pp. 2040-2050
Open Access | Times Cited: 7
Ожирение и ассоциированные с ним заболевания – проблемные вопросы патогенеза и современные стратегии диагностики и лечения
Т. П. Голивец, Diana G. Dubonosova, Сергей Вячеславович Ликризон
Актуальные проблемы медицины (2023) Vol. 46, Iss. 2, pp. 123-143
Open Access | Times Cited: 3
Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis
Carmen Navarrete, Adela García‐Martin, Jim DeMesa, et al.
Current Hypertension Reports (2020) Vol. 22, Iss. 12
Closed Access | Times Cited: 8
Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats
Ilijana Babic, Dominic Sellers, Paul L. Else, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 3, pp. 284-302
Closed Access | Times Cited: 7
Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects
G. S. Vardanyan, H. S. Harutyunyan, M. I. Aghajanov, et al.
Future Medicinal Chemistry (2020) Vol. 12, Iss. 20, pp. 1865-1884
Open Access | Times Cited: 6
RETRACTED: Aerobic exercise training reduces deep-frying oil-induced apoptosis of hippocampal tissue by reducing oxidative stress in male rats
Sina Nikbin, Gita fardad, Sara Yazdi, et al.
Journal of Chemical Neuroanatomy (2023) Vol. 133, pp. 102328-102328
Closed Access | Times Cited: 2
Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies against Obesity and Depression Symptoms
Tiffany Y. Wences Chirino, Edgar Rangel‐López, Alexandra Luna‐Angulo, et al.
(2023)
Open Access | Times Cited: 2
Pharmacology of Endocannabinoids and Their Receptors
Gaurav Gupta, Wafa Hourani, Pran Kishore Deb, et al.
Springer eBooks (2020), pp. 415-445
Closed Access | Times Cited: 4
Role of human carbonic anhydrase isoforms VA and VB in obesity: Implications, mechanisms, and therapeutic prospects
Muhammet KAÇMAZ, Muhammed Trawally, Özlen Güzel AKDEMİR
Journal of Research in Pharmacy (2024) Vol. 28(3), Iss. 28(3), pp. 733-748
Open Access
Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease
Cherry L. Wainwright, Sarah K. Walsh
Handbook of experimental pharmacology (2024)
Closed Access
Obesity – significant medical and social problem of our time: risk factors, pathophysiological determinants, treatment strategies. A review
Elena V. Biryukova
Consilium Medicum (2024) Vol. 26, Iss. 7, pp. 461-469
Open Access
Identification and structural characterization of CB1 receptor antagonists: A comprehensive virtual screening and molecular dynamics study of arachidin-2
Ana C. Murrieta, Paola Mendoza-Espinosa, José Luis Velasco-Bolom, et al.
Biophysical Chemistry (2024) Vol. 318, pp. 107385-107385
Closed Access
Flipping the GPCR Switch: Structure–Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
Erick M. Carreira, Miroslav Kosar, Roman C. Sarott, et al.
(2023)
Open Access | Times Cited: 1
Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms
Tiffany Y. Wences Chirino, Edgar Rangel‐López, Alexandra Luna Angulo, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1421-1421
Open Access | Times Cited: 1
Endocannabinoids: the lipid effectors of metabolic regulation in health and disease
Tony Jourdan, Pascal Degrace, Isabel González‐Mariscal, et al.
Elsevier eBooks (2020), pp. 297-320
Closed Access | Times Cited: 2

Scroll to top